Non-Employee Director Compensation Policy of Integra LifeSciences Holdings Corporation (2016)

Contract Categories: Human Resources › Compensation Agreements
Summary

Integra LifeSciences Holdings Corporation sets out the compensation for its non-employee directors, effective from the 2016 Annual Meeting. Non-employee directors receive an annual equity grant of restricted stock valued at $170,000 ($220,000 for the Chairman) and an annual retainer of $75,000, which can be taken in cash, restricted stock, or a combination. Additional annual cash fees are paid to committee chairs and the Chairman. The company also reimburses reasonable travel and out-of-pocket expenses related to board duties.

Read More Arrow
EX-10.1 2 exhibit10_1xdecember17x2015.htm EXHIBIT 10.1 Exhibit
EXHIBIT 10.1

Compensation of Non-Employee Directors of Integra LifeSciences Holdings Corporation
Effective as of the 2016 Annual Meeting of Stockholders of Integra LifeSciences Holdings Corporation (the “Company”), the annual compensation payable to non-employee directors of the Company will be as set forth below:
Directors will receive an annual equity grant in the form of restricted stock with a fair market value on the date of grant of $170,000 (or $220,000 for the Chairman).
Directors will also receive an annual retainer of $75,000, payable in one of three ways, at their election: (1) in cash, (2) in restricted stock, or (3) one half in cash and one half in restricted stock.
In addition, the Company will pay the following separate annual cash fees, payable quarterly in arrears in accordance with the same timetable that is used for paying the annual retainer fee, to certain directors as follows: (1) $15,000 for the Nominating and Corporate Governance Committee Chair, (2) $15,000 for the Compensation Committee Chair, (3) $15,000 for the Audit Committee Chair, (4) $15,000 for the Finance Committee Chair, (5) $25,000 for the Presiding Director and (6) $75,000 for the Chairman.
The Company will pay reasonable travel and out-of-pocket expenses incurred by non-employee directors in connection with attendance at meetings to transact business of the Company or attendance at meetings of the Board of Directors or any committee thereof.